GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gilead Sciences Inc (BSP:GILD34) » Definitions » Dividend Payout Ratio

Gilead Sciences (BSP:GILD34) Dividend Payout Ratio

: 0.31 (As of Dec. 2023)
View and export this data going back to 2016. Start your Free Trial

Gilead Sciences's dividend payout ratio for the months ended in Dec. 2023 was 0.31.

The historical rank and industry rank for Gilead Sciences's Dividend Payout Ratio or its related term are showing as below:

BSP:GILD34' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.11   Med: 0.48   Max: 0.78
Current: 0.43


During the past 13 years, the highest Dividend Payout Ratio of Gilead Sciences was 0.78. The lowest was 0.11. And the median was 0.48.

BSP:GILD34's Dividend Payout Ratio is ranked worse than
70.66% of 426 companies
in the Drug Manufacturers industry
Industry Median: 0.32 vs BSP:GILD34: 0.43

As of today (2024-04-16), the Dividend Yield % of Gilead Sciences is 3.36%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Gilead Sciences was 4.90%. The lowest was 0.36%. And the median was 3.50%.

Gilead Sciences's Dividends per Share for the months ended in Dec. 2023 was R$1.30.

During the past 12 months, Gilead Sciences's average Dividends Per Share Growth Rate was 2.70% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 3.30% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 5.50% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Gilead Sciences was 20.90% per year. The lowest was 3.30% per year. And the median was 8.50% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Gilead Sciences Dividend Payout Ratio Historical Data

The historical data trend for Gilead Sciences's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gilead Sciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Dividend Payout Ratio
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.36 0.78 0.52 0.50 0.38

Gilead Sciences Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Dividend Payout Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.44 0.69 0.58 0.29 0.31

Competitive Comparison

For the Drug Manufacturers - General subindustry, Gilead Sciences's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gilead Sciences Dividend Payout Ratio Distribution

For the Drug Manufacturers industry and Healthcare sector, Gilead Sciences's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Gilead Sciences's Dividend Payout Ratio falls into.



Gilead Sciences Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Gilead Sciences's Dividend Payout Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Dec. 2023 )/ EPS without NRI (A: Dec. 2023 )
=6.303/ 16.463
=0.38

Gilead Sciences's Dividend Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2023 )/ EPS without NRI (Q: Dec. 2023 )
=1.296/ 4.214
=0.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gilead Sciences (BSP:GILD34) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.


Gilead Sciences Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Gilead Sciences's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Gilead Sciences (BSP:GILD34) Business Description

Address
333 Lakeside Drive, Foster, CA, USA, 94404
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.

Gilead Sciences (BSP:GILD34) Headlines

No Headlines